Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osiris surges 33.4% on 3Q sales boost

This article was originally published in Clinica

Executive Summary

Osiris Therapeutics closed up 33.4% at $17.76 per share on 1 November after the company reported $6.9m in product revenue for the third quarter of 2013. This represented a 220% jump in sales compared with the third quarter of 2012 for its stem cell-based wound healing and biosurgery products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101046

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel